IL10 and systemic lupus erythematosus: In contrast, sCTLA-4 blockade in resting PBMC from SLE patients raised both cell proliferation and IL-10 levels (Fig. 5 and Table 2), suggesting that PBMC in lupus patients seem primed to secrete higher levels of IL-10.